Quantitative Investment Management, LLC
Position in HALO — Halozyme Therapeutics, Inc.
CIK 1445911
CHARLOTTESVILLE, VA
Position in HALO
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,301,708
+$1,024,997 QoQ
Shares Held
16,631
+340.8% QoQ
Ownership
0.015%
of shares outstanding
% of Portfolio
0.19%
of 13F equity value
Holder Rank
#285
of 664 holders
Holding Since
Jun 2020
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in HALO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Quantitative Investment Management, LLC holds $20,430,992 across 8 Biotechnology names. HALO ranks #6 (6.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
13,499 | $8,417,166 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
8,342 | $4,143,721 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
7,981 | $2,402,520 | |
| 4 | INSM |
INSMED Inc
|
15,894 | $1,694,618 | |
| 5 | VKTX |
Viking Therapeutics, Inc.
|
41,416 | $1,615,638 | |
| 6 | HALO |
Halozyme Therapeutics, Inc.
This page
|
16,631 | $1,301,708 | |
| 7 | ASND |
Ascendis Pharma A/S
|
1,985 | $529,439 | |
| 8 | RXRX |
Recursion Pharmaceuticals, Inc.
|
88,878 | $326,182 |
All Filings in HALO
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,301,708 | 16,631 | Shares | Sole | 2026-08-14 | |
| 2025-09-30 | $276,711 | 3,773 | Shares | Sole | 2025-11-13 | |
| 2020-12-31 | $609,258 | 14,265 | Shares | Sole | 2021-02-16 | |
| 2020-06-30 | $633,305 | 23,622 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||